In our clinical tissue samples, patients with high APC expression tended to have longer survival times than those with low APC expression (Supplementary Fig. 3A), while high c-Jun expression appeared to be an unfavorable prognosis factor in glioma patients (Supplementary Fig. 3B). The gene discussed is APC; the disease is central nervous system cancer.